Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-08

Clinical Trial Update: NICardipine Neuroprotection in AortiC Surgery (NICNACS) [Phase 2]

View source ↗

Summary

Phase 2 trial of nicardipine for neuroprotection in thoracic aortic surgery was terminated, with results posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicardipine (nicardipine)

Snippet

Sponsor: Duke University | Conditions: Aortic Aneurysm, Thoracic | Phase 2 | Status: TERMINATED | Results posted: 2013-03-08